Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea

PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
ErythemaRosacea
Interventions
DRUG

CD07805/47 gel 0.5%/CD07805/47 Vehicle

"To maintain masking, CD07805/47 gel 0.5% will be administered along with CD07805/47 gel vehicle.~During each treatment period (baseline to Day 15):~CD07805/47 gel 0.5%, topical, once daily and CD07805/47 gel vehicle, topical, once daily"

DRUG

azelaic acid gel 15%

During each treatment period (baseline to Day 15): azelaic acid gel 15%, topical, twice daily

Trial Locations (4)

24501

The Education & Research Foundation, Inc., Lynchburg

40202

Dermatology Specialists Research, LLC, Louisville

47714

Hudson Dermatology, Evansville

78759

DermResearch, Inc, Austin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Galderma R&D

INDUSTRY